MIAMI—Mission 500, the security industry's nonprofit charity dedicated to supporting children in need across the U.S., Canada, and Puerto Rico, has unveiled a refreshed brand identity ahead of ISC ...

Anacortes Pride revealed its 2025 Pride Festival logo Wednesday, March 19, during its monthly happy hour at Secret Cove ...

In the Fall 2022 semester, Fordham undergraduates in the Logos Branding Art course taught by Professor Abby Goldstein, engaged in research and development of a logo that would be used on materials for ...

Star Wars finally returns to the big screen with next year's The Mandalorian and Grogu, and Lucasfilm has now unveiled the ...

The Delray Beach cultural arts center, now under the city's ownership, launched its 'A Legacy Through Local Art' initiative ...

The new design has gotten mixed reviews from fans. The post Big 12 Commish: Garish Court Design Is ‘Profound Statement,’ Could Go on ‘Branded Luggage’ appeared first on Front Office Sports.

What is Guillain-Barré syndrome? Guillain-Barré syndrome (GBS) is also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It's a neurological disorder in which the body's immune ...

When it comes to recipes, I have a few nonnegotiables: simple, healthy and delicious! These creations are terrific for when you’re craving a quick breakfast or scrumptious afternoon snack: my ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

By spotlighting these ten logos and unpacking their innovations, we will gain insight into how Japanese design principles produce aesthetically striking yet meaningful symbols. We will see how ...

Guillain-Barre Syndrome (pronounced Gee-luhn-Baa Syndrome) or GBS is a rare autoimmune condition in which the immune system attacks the peripheral nerves. It leads to symptoms such as numbness ...

Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting Targeted for 1H 2025 Ahead of Planned Biologics License ...